2020 George A. Uriano Award

The group is cited for increasing the competitiveness of the U.S. biopharmaceutical industry through NIST’s leadership in establishing the DOC’s first Manufacturing USA institute, the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). The team’s collective efforts and expertise inform the critical industry challenges addressed by NIIMBL, establish stakeholders’ confidence in the value of NIIMBL membership, and facilitate NIIMBL’s ability to comply with federal funding requirements and agilely develop partnerships with large and small industry, academic institutions, federal agencies, and non-profits.